MOPEC17 Same-day initiation of emtricitabine-tenofovir disoproxil succinate in a demedicalized model of oral pre-exposure prophylaxis (PrEP) in Mexico: a real-world data analysisPoster exhibitionHIV prevention research
EPC0484 Same day ART initiation, loss to follow-up and viral load suppression among people living with HIV in low- and middle-income countries: a systematic review and meta-analysisE-posterCascades of HIV care and treatment
MOPEB03 Safety and efficacy of 6-month rifampicin resistant TB regimens in people living with HIV: final analysisPoster exhibitionCo-infections (including opportunistic infections)
TUPEB15 Ruxolitinib-mediated HIV-1 reservoir decay in A5336 phase 2a trialPoster exhibitionOther strategies and therapies
EPC0520 Roles of community health workers in advancing health security and resilient health systems: emerging lessons from the COVID 19 pandemic in TanzaniaE-posterEpidemiology of COVID-19
EPA0025 Role of transcriptionally-active "defective" HIV-1 proviruses in immunological non-responders: a case-control studyE-posterHIV pathogenesis
EPB0129 Role of low-risk HPV PCR in screening for HSIL lesions and anal cancer in men who have sex with men (MSM) living with HIV (MSM-LWHIV)E-posterCo-infections (including opportunistic infections)
EPC0409 Role of health care workers in supporting mother mentors to address retention of mother-baby pairs in the global fund-supported regions. A case from Christian Social Services Commission, TanzaniaE-posterSexual and reproductive health and HIV prevention
MOPEE27 Robot-based assessment: a novel tool to objectively quantify the impact of HIV on agingPoster exhibitionImplementation science and scale up of treatment
OALBB0504 Risks of hypertension with first-line dolutegravir (DTG) and tenofovir alafenamide (TAF) in the NAMSAL and ADVANCE trialsOral abstract session with live Q&AClinical complications of HIV and antiretroviral therapy
271 - 280 of 1427 items